|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.40 USD | -3.75% |
|
+3.95% | +54.54% |
| Mar. 03 | Novavax, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 02:30 PM | |
| Feb. 26 | Health Care Down Amid Mixed Earnings -- Health Care Roundup | DJ |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Development of Recombinant Vaccines | 1.15B | 1.98B | 984M | 682M | 1.12B | |||||
Total Assets | 2.58B | 2.26B | 1.8B | 1.56B | 1.18B | |||||
Interest Expense | -21.13M | -19.88M | -14.42M | -20.08M | -22.55M | |||||
Income Tax Expense | 29.22M | 4.29M | 2.03M | 10.88M | 1.86M | |||||
CAPEX | -57.49M | -92.98M | -53.77M | -13.06M | -5.56M | |||||
EBT | -1.71B | -654M | -543M | -177M | 442M | |||||
D&A | 12.66M | 29.05M | 41.22M | 48.5M | 27.61M | |||||
Operating Income | -1.69B | -645M | -567M | -249M | 453M | |||||
Net Income | -1.74B | -658M | -545M | -187M | 440M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Rest of North America | - | - | - | - | 576M | |||||
United States | - | - | - | - | 406M | |||||
Total Assets | - | - | - | - | 60.68M | |||||
Rest of The World | - | 537M | 233M | 31.92M | 126M | |||||
Europe | - | 824M | 268M | 93.27M | 15.74M | |||||
Total Assets | - | - | - | - | 7.02M | |||||
North America | - | 194M | 29.96M | 65.02M | - |
- Stock Market
- Equities
- NVAX Stock
- Financials Novavax, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
